Management of Staghorn Calculi

Primary Treatment Approach

Percutaneous nephrolithotomy (PNL) should be the first-line treatment for most patients with staghorn calculi, as it achieves stone-free rates more than three times greater than shock wave lithotripsy monotherapy with similar complication rates 1, 2, 3
PNL-based techniques are the gold standard due to superior stone-free rates and acceptably low morbidity compared to other modalities 4, 5
The only randomized prospective trial (Meretyk trial) demonstrated PNL achieved stone-free rates >3 times higher than SWL monotherapy 1, 3
Modern PNL utilizes flexible nephroscopy after rigid nephroscopy debulking to remove stones remote from the access tract 5
Single-access PNL with flexible nephroscopy and holmium:YAG laser can achieve 95% stone-free rates with mean 1.6 procedures per patient 5
Second-look flexible nephroscopy via the existing nephrostomy tract retrieves residual stones when identified on post-PNL imaging 5

If combination therapy is used, percutaneous nephroscopy must be the final procedure 1, 2, 3
The optimal sequence is: initial PNL debulking → SWL for residual fragments → final nephroscopy for remaining stones ("sandwich therapy") 4, 5
Nephroscopy is more sensitive than plain radiography for detecting residual fragments and allows accurate stone-free assessment 1, 3
Avoid ending with SWL alone - this approach yields only 23% stone-free rates 1, 3
SWL should only be used for stones unreachable by flexible nephroscopy or unsafe for additional access tracts 1, 3

SWL monotherapy should NOT be used for most patients with staghorn calculi 1, 2, 3
Meta-analysis shows significantly lower stone-free rates than PNL-based approaches 1, 3
Stone-free rates are highly dependent on stone burden - substantially lower for complete versus partial staghorn stones 1, 2, 6
If SWL monotherapy is undertaken despite limitations, establish adequate drainage (ureteral stent or percutaneous nephrostomy) before treatment to facilitate fragment passage and prevent severe obstruction/sepsis 1, 3
Never use SWL monotherapy for cystine staghorn stones - associated with poor stone-free rates for stones ≥25mm 4, 5

Open surgery should NOT be used for most patients - only 2% of Medicare patients underwent open stone procedures by 2000 5
Reserved for extremely large staghorn calculi with unfavorable collecting system anatomy 4
Consider for extreme morbid obesity or skeletal abnormalities that preclude fluoroscopy and endoscopic therapies 4
Anatrophic nephrolithotomy is the preferred open approach when necessary 4
Estimated transfusion rate 20-25% and mortality ~1% 2, 6

Either SWL monotherapy or percutaneous-based therapy may be considered 4, 5
Stone-free rates with SWL approach 80% in children - higher than adults due to body size differences, ureteral elasticity, and length 4, 5
Important caveats: Animal studies show developing kidneys may be more susceptible to SWL bioeffects, and SWL is not FDA-approved for this specific pediatric indication 4, 5

Nephrectomy should be considered when the involved kidney has negligible function and the contralateral kidney is normal 4
Indicated for poorly functioning, chronically infected kidneys with recurrent UTI, pyelonephritis, or sepsis 4

Transfusion rates: <20% for PNL and combination therapy, very low for SWL, 20-25% for open surgery 2, 6
Death is rare but can occur with medical comorbidities or sepsis development 2, 6
Overall significant complications range 13-19% across all four treatment modalities 2, 6

Stone-free rates are substantially higher for partial versus complete staghorn stones across all treatment modalities 1, 2, 6
PNL-based therapy achieves the highest stone-free rates regardless of stone burden 1, 3

Never withhold treatment options from patients due to physician inexperience or local equipment unavailability - patients must be informed of all treatment alternatives 1, 2, 6
Non-contrast CT is the gold standard for determining stone-free status, though fragments adjacent to nephrostomy tubes may not be detected 1, 3